EMEA-001877-PIP01-15-M02
Key facts
| Invented name |
Ajovy
|
| Active substance |
fremanezumab
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0411/2019
|
| PIP number |
EMEA-001877-PIP01-15-M02
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Prevention of migraine headaches
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Teva GmbH
Tel. +41 552201546 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|